152 related articles for article (PubMed ID: 28132807)
21. miR-520b regulates migration of breast cancer cells by targeting hepatitis B X-interacting protein and interleukin-8.
Hu N; Zhang J; Cui W; Kong G; Zhang S; Yue L; Bai X; Zhang Z; Zhang W; Zhang X; Ye L
J Biol Chem; 2011 Apr; 286(15):13714-22. PubMed ID: 21343296
[TBL] [Abstract][Full Text] [Related]
22. The oncoprotein HBXIP promotes migration of breast cancer cells via GCN5-mediated microtubule acetylation.
Li L; Liu B; Zhang X; Ye L
Biochem Biophys Res Commun; 2015 Mar; 458(3):720-725. PubMed ID: 25686500
[TBL] [Abstract][Full Text] [Related]
23. Deacetylation of tumor-suppressor MST1 in Hippo pathway induces its degradation through HBXIP-elevated HDAC6 in promotion of breast cancer growth.
Li L; Fang R; Liu B; Shi H; Wang Y; Zhang W; Zhang X; Ye L
Oncogene; 2016 Aug; 35(31):4048-57. PubMed ID: 26657153
[TBL] [Abstract][Full Text] [Related]
24. Aspirin suppresses the abnormal lipid metabolism in liver cancer cells via disrupting an NFκB-ACSL1 signaling.
Yang G; Wang Y; Feng J; Liu Y; Wang T; Zhao M; Ye L; Zhang X
Biochem Biophys Res Commun; 2017 May; 486(3):827-832. PubMed ID: 28359761
[TBL] [Abstract][Full Text] [Related]
25. HBXIP expression predicts patient prognosis in breast cancer.
Cheng D; Liang B; Li Y
Med Oncol; 2014 Oct; 31(10):210. PubMed ID: 25178941
[TBL] [Abstract][Full Text] [Related]
26. Inflammatory factor TNF-α promotes the growth of breast cancer via the positive feedback loop of TNFR1/NF-κB (and/or p38)/p-STAT3/HBXIP/TNFR1.
Cai X; Cao C; Li J; Chen F; Zhang S; Liu B; Zhang W; Zhang X; Ye L
Oncotarget; 2017 Aug; 8(35):58338-58352. PubMed ID: 28938560
[TBL] [Abstract][Full Text] [Related]
27. The oncoprotein HBXIP up-regulates SCG3 through modulating E2F1 and miR-509-3p in hepatoma cells.
Wang Y; Cui M; Cai X; Sun B; Liu F; Zhang X; Ye L
Cancer Lett; 2014 Oct; 352(2):169-78. PubMed ID: 24882622
[TBL] [Abstract][Full Text] [Related]
28. Characterization of the promoter region of the bovine long-chain acyl-CoA synthetase 1 gene: Roles of E2F1, Sp1, KLF15, and E2F4.
Zhao ZD; Zan LS; Li AN; Cheng G; Li SJ; Zhang YR; Wang XY; Zhang YY
Sci Rep; 2016 Jan; 6():19661. PubMed ID: 26782942
[TBL] [Abstract][Full Text] [Related]
29. Transcriptional regulation of acetoacetyl-CoA synthetase by Sp1 in neuroblastoma cells.
Hasegawa S; Imai M; Yamasaki M; Takahashi N; Fukui T
Biochem Biophys Res Commun; 2018 Jan; 495(1):652-658. PubMed ID: 29137983
[TBL] [Abstract][Full Text] [Related]
30. HBXIP is a novel regulator of the unfolded protein response that sustains tamoxifen resistance in ER+ breast cancer.
Zhang S; Wang R; Wang X; Guo X; Du Y; Guo X; Zong X; Zhu C; Zhou X
J Biol Chem; 2022 Mar; 298(3):101644. PubMed ID: 35093383
[TBL] [Abstract][Full Text] [Related]
31. The nuclear import of oncoprotein hepatitis B X-interacting protein depends on interacting with c-Fos and phosphorylation of both proteins in breast cancer cells.
Zhang Y; Zhao Y; Li H; Li Y; Cai X; Shen Y; Shi H; Li L; Liu Q; Zhang X; Ye L
J Biol Chem; 2013 Jun; 288(26):18961-74. PubMed ID: 23667255
[TBL] [Abstract][Full Text] [Related]
32. HBXIP and LSD1 Scaffolded by lncRNA Hotair Mediate Transcriptional Activation by c-Myc.
Li Y; Wang Z; Shi H; Li H; Li L; Fang R; Cai X; Liu B; Zhang X; Ye L
Cancer Res; 2016 Jan; 76(2):293-304. PubMed ID: 26719542
[TBL] [Abstract][Full Text] [Related]
33. HBXIP suppression reduces cell proliferation and migration and its overexpression predicts poor prognosis in non-small-cell lung cancer.
Wang Y; Li N; Che S; Jin T; Piao J; Liu S; Lin Z
Tumour Biol; 2017 Jul; 39(7):1010428317709675. PubMed ID: 28718367
[TBL] [Abstract][Full Text] [Related]
34. Long noncoding RNA HULC modulates abnormal lipid metabolism in hepatoma cells through an miR-9-mediated RXRA signaling pathway.
Cui M; Xiao Z; Wang Y; Zheng M; Song T; Cai X; Sun B; Ye L; Zhang X
Cancer Res; 2015 Mar; 75(5):846-57. PubMed ID: 25592151
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis B X-interacting protein promotes cisplatin resistance and regulates CD147 via Sp1 in ovarian cancer.
Zou W; Ma X; Yang H; Hua W; Chen B; Cai G
Exp Biol Med (Maywood); 2017 Mar; 242(5):497-504. PubMed ID: 28056551
[TBL] [Abstract][Full Text] [Related]
36. HBXIP overexpression is correlated with the clinical features and survival outcome of ovarian cancer.
Wang Y; Sun J; Li N; Che S; Jin T; Liu S; Lin Z
J Ovarian Res; 2017 Apr; 10(1):26. PubMed ID: 28388957
[TBL] [Abstract][Full Text] [Related]
37. HBXIP regulates etoposide-induced cell cycle checkpoints and apoptosis in MCF-7 human breast carcinoma cells.
Fei HR; Li ZJ; Ying-Zhang ; Yue-Liu ; Wang FZ
Gene; 2018 Mar; 647():39-47. PubMed ID: 29309885
[TBL] [Abstract][Full Text] [Related]
38. Association of long-chain acyl-coenzyme A synthetase 5 expression in human breast cancer by estrogen receptor status and its clinical significance.
Yen MC; Kan JY; Hsieh CJ; Kuo PL; Hou MF; Hsu YL
Oncol Rep; 2017 Jun; 37(6):3253-3260. PubMed ID: 28498416
[TBL] [Abstract][Full Text] [Related]
39. The modulation of PD-L1 induced by the oncogenic HBXIP for breast cancer growth.
Xu FF; Sun HM; Fang RP; Zhang L; Shi H; Wang X; Fu XL; Li XM; Shi XH; Wu Y; Ye K; Zhang WY; Ye LH
Acta Pharmacol Sin; 2022 Feb; 43(2):429-445. PubMed ID: 33824459
[TBL] [Abstract][Full Text] [Related]
40. The LPI/GPR55 axis enhances human breast cancer cell migration via HBXIP and p-MLC signaling.
Zhou XL; Guo X; Song YP; Zhu CY; Zou W
Acta Pharmacol Sin; 2018 Mar; 39(3):459-471. PubMed ID: 29188802
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
